Latest Healthcare Research Reports

Tag: male hypogonadism market research

  • How is the Male Hypogonadism Market Poised for Growth: Trends and Opportunities Through 2034

    How is the Male Hypogonadism Market Poised for Growth: Trends and Opportunities Through 2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the male hypogonadism market grown in recent years?

    The market for male hypogonadism has seen substantial growth in recent years. Its size is forecasted to increase from $3.75 billion in 2024 to $3.99 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Various factors including the aging population, public awareness and diagnosis, lifestyle factors, chronic illnesses, and a tendency to seek treatment have contributed to the growth observed in the historical period.

    How is the male hypogonadism market size expected to evolve during the forecast period?

    The market size for male hypogonadism is anticipated to significantly expand in the coming years, projecting a growth to $5.08 billion by 2029, with a compound annual growth rate (CAGR) of 6.2%. The projected growth within this period can be credited to factors such as increased awareness, the prevalence of lifestyle-associated conditions, breakthroughs in treatment methods, emphasis on male health, telemedicine, and accessibility of healthcare. The forecasted period will also witness major trends including a focus on mental and sexual health, the exploration of nutraceuticals and lifestyle modifications, market growth in developing economies, joint research efforts, and an emphasis on long-term safety and monitoring.

    Get your male hypogonadism market report here!

    https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

    Which key drivers are propelling the male hypogonadism market’s growth?

    The escalation in infertility rates is predicted to spur the expansion of the male hypogonadism market in the future. Infertility is a disorder impacting the reproductive system of either gender and it is typified by an inability to conceive despite having regular unprotected sexual relations for a year or longer. Male hypogonadism, a potential cause of male infertility that could lead to a decrease in sperm production, is thereby implicated. Consequently, the growing incidence of male infertility is projected to fuel the male hypogonadism market’s growth. For instance, the UK’s Office for National Statistics reported in February 2024 that in 2022, the total fertility rate (TFR) escalated to 1.49 children per woman from 1.55 in 2021. Hence, the rising infertility rate is propelling the expansion of the male hypogonadism market.

    What are the market segments in the male hypogonadism industry?

    The male hypogonadism market covered in this report is segmented –

    1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types

    2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries

    3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy

    Subsegments:

    1) By Klinefelter’s Syndrome: 47,XXY Syndrome, Other Variants

    2) By Kallmann Syndrome: Isolated Kallmann Syndrome, Syndromic Kallmann Syndrome

    3) By Pituitary Disorders: Hypopituitarism, Pituitary Tumors, Other Pituitary Disorders

    4) By Other Types: Androgen Insensitivity Syndrome, Testicular Dysgenesis Syndrome, Genetic Mutations And Disorders

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp

    Which leading companies are shaping the growth of the male hypogonadism market?

    Major companies operating in the male hypogonadism market include Pfizer Inc., Bayer AG, Eli Lilly and Company Ltd., Endo International plc., Merck & Co. Inc., Ferring Pharmaceuticals, Finox Biotech AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Perrigo Company plc, IBSA Institut Biochimique SA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Limited, Antares Pharma Inc., Zydus Cadila LLC, Besins Healthcare Ltd., Clarus Therapeutics Holdings Inc., Foresee Pharmaceuticals Co. Ltd., Lipocine Inc., Myovant Sciences Ltd., Sandoz International GmbH, Shionogi & Co. Ltd., TherapeuticsMD Inc., Viking Therapeutics Inc.

    What key trends are currently impacting the male hypogonadism market’s development?

    Product innovation is emerging as a significant trend in the male hypogonadism marketplace. Companies in this sector are engineering new products to maintain their market standing. For example, Halozyme, an American biotech organization, unveiled Tlando in June 2022, an oral medication for testosterone replacement therapy for male hypogonadism. Tlando, a testosterone-containing prescription medicine, is the first orally administered testosterone treatment to receive FDA approval. The aim is to treat adult men who suffer from low to no testosterone levels due to various health conditions.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9969

    Which geographic areas are influencing the growth of the male hypogonadism market?

    North America was the largest region in the male hypogonadism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the male hypogonadism market report during the forecast period. The regions covered in the male hypogonadism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    Biosimilar Therapeutic Peptides Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report

    Gastrointestinal Bleeding Treatment Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Medication Adherence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/medication-adherence-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Male Hypogonadism Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

    Male Hypogonadism Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What Growth Opportunities are Expected to Drive the Male Hypogonadism Market’s CAGR Through 2034?

    The market size for male hypogonadism has experienced significant growth in the past few years. The market predictions suggest a rise from $3.75 billion in 2024 to $3.99 billion in 2025, showing a compound annual growth rate (CAGR) of 6.3%. This growth over the historic period has been due to factors such as an older population, increased knowledge and diagnosis, lifestyle considerations, chronic diseases, and the behavior associated with seeking treatment.

    In the coming years, we can expect the market size for male hypogonadism to experience significant growth, soaring to a whopping $5.08 billion in 2029. This increase represents a compound annual growth rate (CAGR) of 6.2%. This rising trend anticipated over the forecast period can be attributed to a variety of factors; this includes increased awareness, the pervasiveness of lifestyle-associated conditions, therapy innovations, a growing focus on male health, the emergence of telemedicine and greater access to healthcare. Other trends to watch for within this forecast period include a stronger focus on mental and sexual health, the utilization of nutraceuticals and lifestyle adjustments, market proliferation in developing economies, partnerships fostered for research purposes, and an emphasis on long-term safety and vigilance.

    Which Drivers Are Expected to Have the Greatest Impact on the male hypogonadism Market’s Growth?

    The surge in rates of infertility is anticipated to spur the expansion of the male hypogonadism market. Infertility is defined as an issue that affects the reproductive systems of males or females, culminating in a failure to conceive after a year or more of regular, unprotected sex. Decreased sperm generation and infertility could result from male hypogonadism, a possible reason for male infertility. Consequently, the escalating occurrence of male infertility is predicted to propel the male hypogonadism market’s expansion. For example, the Total Fertility Rate (TFR) saw an increase to 1.49 children per woman in 2022, a jump from 1.55 in 2021, according to the Office for National Statistics, a government department in the UK, in February 2024. Thus, the rise in infertility rates is stimulating the growth of the male hypogonadism market.

    Get Your Free Sample of the Global Male Hypogonadism Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp

    What Are the Leading Industry Players Dominating the Male Hypogonadism Market?

    Major companies operating in the male hypogonadism market include:

    • Pfizer Inc._x000D_

    • Bayer AG_x000D_

    • Eli Lilly and Company Ltd._x000D_

    • Endo International plc._x000D_

    • Merck & Co. Inc._x000D_

    What Are the Latest Trends Leading to Disruption in the Male Hypogonadism Market?

    A significant trend that is gaining traction in the male hypogonadism market is the innovation of new products. To maintain their standings in the market, corporations in this sector are developing novel products. For example, in June 2022, the American biotechnology firm, Halozyme, introduced Tlando, an oral medication for the testosterone replacement treatment for male hypogonadism. This prescription medication, which contains testosterone, is the first orally-administered testosterone treatment to receive FDA approval. It is prescribed to treat adult males who suffer from low or no testosterone due to specific medical conditions.

    Get Instant Access to the Global Male Hypogonadism Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

    What Are the Strategic Segments Comprising the Male Hypogonadism Market and Their Growth Contributions?

    The male hypogonadism market covered in this report is segmented –

    1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types

    2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries

    3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy

    Subsegments:

    1) By Klinefelter’s Syndrome: 47,XXY Syndrome, Other Variants

    2) By Kallmann Syndrome: Isolated Kallmann Syndrome, Syndromic Kallmann Syndrome

    3) By Pituitary Disorders: Hypopituitarism, Pituitary Tumors, Other Pituitary Disorders

    4) By Other Types: Androgen Insensitivity Syndrome, Testicular Dysgenesis Syndrome, Genetic Mutations And Disorders

    Which Regions Are Significant to the Growth of the Male Hypogonadism Market?

    North America was the largest region in the male hypogonadism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the male hypogonadism market report during the forecast period. The regions covered in the male hypogonadism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    How Can We Define the Male Hypogonadism Market and Its Key Components?

    Male hypogonadism is a disease in which the body produces insufficient amounts of the hormone testosterone. Testosterone is the primary male sex hormone and is essential for the development and growth of men throughout puberty.

    Browse Through More Similar Reports By The Business Research Company:

    Biosimilar Therapeutic Peptides Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/biosimilar-therapeutic-peptide-global-market-report

    Gastrointestinal Bleeding Treatment Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/gastrointestinal-bleeding-treatment-devices-global-market-report

    Medication Adherence Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/medication-adherence-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 2024-2033 Male Hypogonadism Market Outlook: Unlocking Growth Potential

    2024-2033 Male Hypogonadism Market Outlook: Unlocking Growth Potential

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Anticipated CAGR of the Male Hypogonadism Market Over the 2024-2033 Forecast Period?

    The market size for male hypogonadism has experienced significant growth in the recent past. It is projected to escalate from $3.55 billion in 2023 to $3.8 billion in 2024, with a compound annual growth rate (CAGR) of 6.8%. The surge during the past period is evident due to factors such as an aging population, increased awareness and diagnosis, lifestyle aspects, chronic ailments, and the tendency to seek treatment.

    Expectations are that the male hypogonadism market will experience a significant increase in size over the upcoming years. By 2028, it is projected to reach $4.77 billion, driven by a compound annual growth rate (CAGR) of 5.9%. This growth throughout the forecast period can be attributed to a range of factors, including increased awareness, more prevalent lifestyle-related conditions, therapeutic innovations, a focus on men’s health, and improved access to both telemedicine and healthcare. Key trends predicted throughout this period include a heightened focus on both psychological and sexual health, an exploration into the potential of nutraceuticals and lifestyle changes, expanding markets in emerging economies, cooperative research initiatives, and a concentration on long-term safety and observation.

    Claim Your Free Sample of the Global Male Hypogonadism Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp

    What Are the Driving Forces Behind the Growth of the male hypogonadism Market?

    The surge in infertility rates is anticipated to boost the expansion of the male hypogonadism market in the future. Infertility is a disorder that affects the reproductive system of both men and women, defined by the inability to get pregnant after one year or more of regular, unprotected sex. One of the potential reasons for male infertility is male hypogonadism, which can result in reduced sperm production and infertility. Therefore, the escalating prevalence of male infertility is projected to foster the growth of the male hypogonadism market. For example, as per the National Institutes of Health (NIH), a Department of Health and Human Services in the US, in March 2023, the male infertility rate range is estimated to be from 4.5% to 6%, around 9% in Australia, and potentially between 8%-12% in Eastern Europe. Furthermore, a study conducted in 2021 and issued by the Libyan Journal of Medical Sciences estimates that approximately 70% of infertility in Libya is due to male factors. As such, an increase in the rate of infertility contributes to the growth of the male hypogonadism market.

    What Are the Core Segments of the Male Hypogonadism Market?

    1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types

    2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries

    3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy

    What Are the Key Innovations Reshaping the Male Hypogonadism Market?

    The emergence of product innovations is a prominent trend in the male hypogonadism market. Businesses in this sector are creating new products to maintain their market stance. For example, in June 2022, US biotech firm Halozyme launched Tlando, a testosterone replacement therapy for male hypogonadism. Tlando, a prescription medication packed with testosterone, is the first orally-administered testosterone treatment to gain FDA approval. It is utilized to help adult men suffering from certain medical conditions causing low or no testosterone.

    Order Now for Fast Delivery of Your Male Hypogonadism Market Report!

    https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

    What Regions Are Influencing the Dynamics of the Male Hypogonadism Market?

    North America was the largest region in the male hypogonadism market in 2023. Asia-Pacific is expected to be the fastest-growing region in the male hypogonadism market report during the forecast period. The regions covered in the male hypogonadism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Male Hypogonadism Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the male hypogonadism market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Male Hypogonadism Market Include

    1. Male Hypogonadism Market Executive Summary

    2. Male Hypogonadism Market Segments

    3. Male Hypogonadism Market Size And Template Market Growth Rate

    4. Key Male Hypogonadism Market Trends

    5. Major Male Hypogonadism Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Male Hypogonadism Market

    26. Top Male Hypogonadism Companies

    27. Male Hypogonadism Market Opportunities And Strategies

    28. Male Hypogonadism Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Growth Trajectory Of The Male Hypogonadism Market 2024-2033

    Growth Trajectory Of The Male Hypogonadism Market 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Market Expansion and Evolution

    • The male hypogonadism market has witnessed robust growth, escalating from $3.55 billion in 2023 to $3.8 billion in 2024, with a commendable CAGR of 6.8%.
    • The historic growth trajectory owes its momentum to an aging population, increased awareness, lifestyle factors, chronic illnesses, and evolving treatment-seeking behaviors.
    • Future projections indicate continued strong growth, with the market anticipated to reach $4.77 billion by 2028, driven by rising awareness, lifestyle-related conditions, therapy innovations, and a focus on men’s health.

    Unveiling the Driving Forces: Rising Infertility Rates

    • The surge in infertility rates acts as a catalyst for male hypogonadism market growth.
    • Male hypogonadism, contributing to decreased sperm production and infertility, emerges as a significant factor in male infertility.
    • Reports from institutions like the NIH and the Libyan Journal of Medical Sciences highlight escalating male infertility rates, propelling the male hypogonadism market forward.

    View More On The Male Hypogonadism Market Report 2024 – https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report

    Innovative Products Redefining Treatment Paradigms

    • Major companies in the male hypogonadism market are pioneering innovative products, including digital-forward platforms and telemedicine solutions.
    • Platforms like Base Healthcare’s men’s virtual health platform offer subscription-based access to virtual health services, oral testosterone treatment, and personalized health guidance.
    • Strategic acquisitions, such as Gruenenthal’s acquisition of Nebido from Bayer AG, bolster product portfolios and pave the way for research and development in male hypogonadism treatment.

    Market Segmentation: Insights and Dynamics

    • The male hypogonadism market segmentation includes types such as Klinefelter’s syndrome, Kallmann syndrome, pituitary disorders, and others.
    • Drug delivery methods encompass topical gels, injectables, transdermal patches, and other innovative drug delivery systems.
    • Therapies like testosterone therapy and gonadotropin-releasing hormone therapy offer diverse treatment options for patients.

    Regional Dynamics: Market Expansion and Growth Prospects

    • North America emerges as the dominant region in the male hypogonadism market in 2023, reflecting significant market share.
    • Asia-Pacific stands out as the fastest-growing region, driven by technological advancements, rising healthcare awareness, and expanding patient populations.

    Conclusion: Pioneering Advances in Men’s Health

    The male hypogonadism market continues to evolve, fueled by rising infertility rates, innovative product developments, and a growing emphasis on men’s health. As awareness spreads and treatment options expand, stakeholders across the healthcare spectrum play a pivotal role in shaping the market’s trajectory. With a focus on long-term safety, treatment efficacy, and patient well-being, the male hypogonadism market stands poised for continued growth and innovation. Collaborative efforts, strategic acquisitions, and advancements in telemedicine herald a new era of accessible and personalized care for individuals affected by male hypogonadism. As the market journey unfolds, stakeholders navigate a landscape ripe with opportunities to revolutionize men’s health and transform lives through innovative treatment modalities and patient-centric care.

    Request A Sample Of The Global Male Hypogonadism Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=9969&type=smp